Preferred Label : Hyperphosphatasia with impaired intellectual development syndrome 3;
Symbol : HPMRS3;
CISMeF acronym : GPIBD8; HPMRS3; MRT17; MRT21;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Mental retardation, autosomal recessive 17; MRT21; GPIBD8; Mental retardation, autosomal recessive 21; MRT17; Glycosylphosphatidylinositol biosynthesis defect 8;
Description : Hyperphosphatasia with mental retardation syndrome-3 is an autosomal recessive disorder
usually characterized by severe mental retardation, hypotonia with very poor motor
development, poor speech, and increased serum alkaline phosphatase (summary by Hansen
et al., 2013). However, the severity of the disorder can also vary to include milder
intellectual disability (Krawitz et al., 2013). For a discussion of genetic heterogeneity
of HPMRS, see HPMRS1 (239300).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the post-GPI attachment to proteins 2 gene (PGAP2, 615187.0001);
Laboratory abnormalities : Increased serum alkaline phosphatase; Hyperphosphatemia;
Prefixed ID : #614207;
Origin ID : 614207;
UMLS CUI : C3280153;
Automatic exact mappings (from CISMeF team)
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)